Login / Signup
Follow
Call Us: (+91) 89626-12340
[email protected]
Signup|Login As :
Subscriber
|
Author
|
Reviewer
|
Editor
| Follow Us:
Call Us: +4 (800)
888-0008
Home
+
Journals
Editors
+
Pharmaceutical
Engineering & Technology
Business Management
Health Sciences
Authors
+
Subscribe
+
Contact Us
+
Inventi Impact: Biosimilars & Biopharmaceuticals
Home
Editorial Board
Current Issue
Past Issues
Patent Watch
Articles
Inventi:pbs/27796/18
A Comparative Clinical Study of PF- 06410293, a Candidate Adalimumab Biosimilar, and\nAdalimumab Reference Product (Humira®) in the Treatment of Active Rheumatoid Arthritis
Research
2019 : January - March
Roy M Fleischmann, Rieke Alten, Margarita Pileckyte, Kasia Lobello, Steven Y Hua, Carol Cronenberger, Daniel Alvarez, Amy E Bock, K Lea Sewell
notavailable
How to Cite this Article
Fleischmann, Roy M., et al. \"A comparative\nclinical study of PF-06410293, a candidate adalimumab biosimilar,\nand adalimumab reference product (Humira®) in the treatment of\nactive rheumatoid arthritis.\" Arthritis research & therapy 20.1\n(2018): 178, https://doi.org/10.1186/s13075-018-1676-y, http://\ncreativecommons.org/licenses/by/4.0/.
Download Full Text
Loading....